Center of Excellence

aCROss Vision

Where Ophthalmology Expertise Meets Clinical Excellence

Discuss Your Study
aCROss Vision

Ophthalmology is one of medicine's most specialized fields. Its trials demand precision, subspecialty knowledge, and teams who truly understand the pathophysiology, the endpoints, and the regulatory landscape.

aCROss Vision was built for exactly that.

As a dedicated division of aCROss Medical, we bring deep, hands-on experience across ophthalmology's most complex subspecialties - backed by the full operational power of a global CRO.

Every Subspecialty Has Its Challenges. We Know Them All.

Retina
The most complex endpoints in ophthalmology. AMD, diabetic retinopathy, rare dystrophies - we've navigated them all.
Glaucoma
From IOP-lowering agents to MIGS devices - medical, surgical, and everything between.
Cornea
Transplantation, surface disease, regenerative approaches - we handle the full spectrum.
Cataract & IOL
Premium lens trials, phacoemulsification studies, surgical outcomes - done and delivered.
Refractive
LASIK, SMILE, emerging technologies - we move as fast as the field does.
Anterior Chamber
Uveitis / inflammation

Full Spectrum of Ophthalmic Trial Types

Pharma & Biologics
Medical Devices & Ocular Implants
Surgical Procedures
Drug-Device Combinations
Advanced Therapies incl. Cell & Gene
Expert Contract Auditor

We also offer expert contract auditing services for ophthalmology clinical trials.

View our published ophthalmology trials
Why It Matters

Ophthalmic trials are unlike any others. Endpoints are visual, subjective, and sensitive. Patient populations are often elderly or pediatric. Regulatory requirements vary across markets. And enrollment - in a field where patients may have limited vision - requires exceptional site management and patient care.

Our teams understand all of this. Not from textbooks - from experience.

YS
Yoram Solberg, MD, PhD
Ophthalmologist & Chief Medical Officer

Other Therapeutic Areas

ICU Stem Cells General Surgery Infectious Disease OBGYN Oncology Respiratory Vascular

Let's Talk About Your Study

Whether you're developing a novel biologic for retinal disease, a next-generation IOL, or a cell therapy for corneal regeneration - we'd love to hear about your program.

Discuss Your Study